ACM
LLY icon

Anfield Capital Management’s Eli Lilly LLY Stock Holding History

Anfield Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Buy
281
+253
+904% +$256K 0.07% 99
2025
Q4 		$30.1K Buy
28
+2
+8% +$1.91K 0.01% 229
2025
Q3 		$19.8K Buy
26
+11
+73% +$8.19K 0.01% 253
2025
Q2 		$11.7K Hold
15
– – ﹤0.01% 280
2025
Q1 		$12.4K Sell
15
-1,548
-99% -$1.29M ﹤0.01% 219
2024
Q4 		$1.21M Hold
1,563
– – 0.44% 39
2024
Q3 		$1.38M Buy
1,563
+1,548
+10,320% +$1.39M 0.53% 36
2024
Q2 		$13.6K Sell
15
-1,724
-99% -$1.38M 0.01% 162
2024
Q1 		$1.35M Buy
+1,739
New +$1.24M 0.65% 34
2020
Q1 		– Sell
-544
Closed -$80K – 259
2019
Q4 		$80K Buy
+544
New +$63.1K 0.03% 183

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Anfield Capital Management's LLY Position: Q1 2026 in Review

Anfield Capital Management increased its Eli Lilly (LLY) stake by 904% in Q1 2026, buying an estimated $256K and bringing the position to 281 shares worth $259K. The position accounts for 0.07% of the portfolio, ranked #99.

Anfield Capital Management first reported a position in LLY in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.38M in Q3 2024. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Anfield Capital Management held 281 shares of Eli Lilly worth $259K as of Q1 2026.
  • Anfield Capital Management bought 253 Eli Lilly shares in Q1 2026, an estimated $256K.
  • Eli Lilly made up 0.07% of Anfield Capital Management's portfolio in Q1 2026, its #99 holding.
  • Anfield Capital Management first reported a position in Eli Lilly in Q4 2019 and has held it in 10 quarters since.
  • Anfield Capital Management's Eli Lilly position peaked at $1.38M in Q3 2024.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.